1. Home
  2. PIPR vs BLCO Comparison

PIPR vs BLCO Comparison

Compare PIPR & BLCO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Piper Sandler Companies

PIPR

Piper Sandler Companies

HOLD

Current Price

$378.29

Market Cap

5.8B

Sector

Finance

ML Signal

HOLD

Logo Bausch + Lomb Corporation

BLCO

Bausch + Lomb Corporation

HOLD

Current Price

$17.38

Market Cap

6.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
PIPR
BLCO
Founded
1895
1853
Country
United States
Canada
Employees
N/A
N/A
Industry
Investment Bankers/Brokers/Service
Ophthalmic Goods
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.8B
6.0B
IPO Year
N/A
2022

Fundamental Metrics

Financial Performance
Metric
PIPR
BLCO
Price
$378.29
$17.38
Analyst Decision
Buy
Hold
Analyst Count
3
14
Target Price
$362.50
$17.31
AVG Volume (30 Days)
121.2K
342.5K
Earning Date
02-06-2026
02-18-2026
Dividend Yield
1.55%
N/A
EPS Growth
42.49
N/A
EPS
13.30
N/A
Revenue
$1,717,433,000.00
$4,976,000,000.00
Revenue This Year
$17.11
$8.06
Revenue Next Year
$15.11
$5.79
P/E Ratio
$28.17
N/A
Revenue Growth
13.46
6.23
52 Week Low
$202.91
$10.45
52 Week High
$377.01
$18.14

Technical Indicators

Market Signals
Indicator
PIPR
BLCO
Relative Strength Index (RSI) 67.46 59.29
Support Level $351.36 $17.18
Resistance Level $371.99 $17.86
Average True Range (ATR) 9.23 0.42
MACD 1.42 -0.01
Stochastic Oscillator 98.49 72.56

Price Performance

Historical Comparison
PIPR
BLCO

About PIPR Piper Sandler Companies

Piper Sandler Cos is an investment bank and institutional securities firm, serving the needs of corporations, private equity groups, public entities, non-profit entities and institutional investors in the United States (U.S.) and internationally. The company provides a broad set of products and services, including financial advisory services; equity and debt capital markets products; public finance services; institutional brokerage services; fundamental equity and macro research services; fixed income services; and alternative asset management strategies. It generates maximum revenue from Advisory services followed by Equity financing.

About BLCO Bausch + Lomb Corporation

Bausch & Lomb is one of the largest vision care companies in the US. The firm was previously a subsidiary under parent company Bausch Health and it was spun off to become a public company in 2022. It operates in three segments: vision care, surgical, and ophthalmic pharmaceuticals. Vision care is composed of contact lenses, a market that B&L controls 10%, and ocular health products, which includes Biotrue and Lumify. Surgical includes a suite of intraocular lenses, equipment for cataract and vitreoretinal surgeries, as well as surgical instruments. Ophthalmic pharmaceuticals has a diverse lineup of products, including Xipere, Vyzulta, and Lotemax that treat different complications. With over 100 products, B&L has the largest portfolio of eye care prescriptions in the space.

Share on Social Networks: